Freenome has entered an exclusive licence agreement with Exact Sciences, granting the latter the rights to commercialise Freenome's blood-based CRC screening test in the US.

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, ...

Solventum (NYSE:SOLV) shares rose after hours today on second-quarter results that came in ahead of the consensus forecast.

Advanced Industrial, a leading force in high-precision component manufacturing, today announced continued excellence in its ...

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - ...

More states are passing laws to protect information generated by a person's brain and nervous system as technology improves ...

We anticipate LivaNova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...

ALPHARETTA, Ga., July 31, 2025 /PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a ...

CR shares the best security gear for your home, tips on avoiding slips and falls, and the smartest financial moves—everything ...

Baxter (NYSE: BAX) + shares fell sharply today on second-quarter results that came up shy of the consensus forecast. Shares ...

Stryker remains a top-tier competitor in a number of attractive medical markets, including orthopedic implants, surgical instruments, endoscopy, and neurovascular devices. It enjoys a long record of ...

The person I spoke with asked if I was sure I didn’t need the phone for medical devices. I already felt ancient — when more ...